HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics Plc (NBRV), sold 2,695 shares at $10.52 ($28K) on 2017-07-05, disclosed to the SEC on 2017-07-07.
Open-market sale of $28k NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.52 | 2,562 | $27K | 95.1% |
| 2 | $10.50 | 133 | $1K | 4.9% |
| Total | $10.52 avg | 2,695 | $28K | 100% |
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |